Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 5

Results: 16

Serum IL‐35 levels is a new candidate biomarker of cancer‐related cachexia in stage IV non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 716, doi. 10.1111/1759-7714.14307

By:

Li, Zengxun;
Zhu, Lei;
Zheng, Han;
Jiang, Wenna;
Wang, Yifei;
Jiang, Zhansheng;
Xu, Jie

Publication type:

Article

New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 708, doi. 10.1111/1759-7714.14302

By:

Kameyama, Komei;
Imai, Kazuhiro;
Ishiyama, Koichi;
Takashima, Shinogu;
Kuriyama, Shoji;
Atari, Maiko;
Ishii, Yoshiaki;
Kobayashi, Akihito;
Takahashi, Shugo;
Kobayashi, Mirai;
Harata, Yuzu;
Sato, Yusuke;
Motoyama, Satoru;
Hashimoto, Manabu;
Nomura, Kyoko;
Minamiya, Yoshihiro

Publication type:

Article

The impact of COVID‐19 on new mesothelioma diagnoses in Italy.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 702, doi. 10.1111/1759-7714.14296

By:

Mangone, Lucia;
Mancuso, Pamela;
Bisceglia, Isabella;
Giorgi Rossi, Paolo;
Chellini, Elisabetta;
Negro, Corrado;
Benfatto, Lucia;
Migliore, Enrica;
Casotto, Veronica;
Mensi, Carolina;
Romanelli, Antonio;
Tumino, Rosario;
Grappasonni, Iolanda;
Cavone, Domenica;
Mazzoleni, Guido;
Tallarigo, Federico;
Marinaccio, Alessandro

Publication type:

Article

Lung cancer risk prediction models based on pulmonary nodules: A systematic review.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 664, doi. 10.1111/1759-7714.14333

By:

Wu, Zheng;
Wang, Fei;
Cao, Wei;
Qin, Chao;
Dong, Xuesi;
Yang, Zhuoyu;
Zheng, Yadi;
Luo, Zilin;
Zhao, Liang;
Yu, Yiwen;
Xu, Yongjie;
Li, Jiang;
Tang, Wei;
Shen, Sipeng;
Wu, Ning;
Tan, Fengwei;
Li, Ni;
He, Jie

Publication type:

Article

Postoperative radiotherapy for patients with completely resected stage IIIA‐N2 non‐small cell lung cancer: opt‐in or opt‐out.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 659, doi. 10.1111/1759-7714.14335

By:

Zhu, Lucheng;
Xia, Bing;
Ma, Shenglin

Publication type:

Article

ERRATUM.

Published in:: 2022
Publication type:: Correction Notice

The deubiquitinase OTUD1 inhibits non‐small cell lung cancer progression by deubiquitinating and stabilizing KLF4.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 761, doi. 10.1111/1759-7714.14320

By:

Ma, Xiaoyan;
Wang, Liming;
Shi, Guifang;
Sun, Shuqing

Publication type:

Article

Durable response to durvalumab‐based immunochemotherapy in small‐cell lung carcinoma transformation from EGFR‐mutant non–small cell lung cancer: A case report.

Published in:: Thoracic Cancer, 2022, v. 13, n. 5, p. 775, doi. 10.1111/1759-7714.14325
Publication type:: Article

Knockdown of circ‐RAD23B inhibits non‐small cell lung cancer progression via the miR‐142‐3p/MAP4K3 axis.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 750, doi. 10.1111/1759-7714.14319

By:

Zhuang, Qingyang;
Huang, Zhangzhou;
Zhuang, Wu;
Hong, Yaping;
Huang, Yunjian

Publication type:

Article

Effect of microRNA‐181b on the biological characteristics and clinical drug resistance of small‐cell lung cancer by targeting angiotensin converting enzyme 2.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 742, doi. 10.1111/1759-7714.14313

By:

Yang, Guang;
Wang, Wenhao;
Han, Shaohui;
Xu, Siwei;
Liu, Huining

Publication type:

Article

Local consolidative therapy for synchronous oligometastatic non‐small cell lung cancer treated with first‐line pembrolizumab: A retrospective observational study.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 732, doi. 10.1111/1759-7714.14312

By:

Chen, Ya;
Wang, Yanan;
Yang, Zhengyu;
Hu, Minjuan;
Lu, Jun;
Zhang, Yanwei;
Qian, Fangfei;
Zhang, Bo;
Wang, Shuyuan;
Wang, Kai;
Zhang, Wei;
Han, Baohui

Publication type:

Article

Risk factors for pneumonitis in patients with non‐small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective analysis.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 724, doi. 10.1111/1759-7714.14308

By:

Yamaguchi, Teppei;
Shimizu, Junichi;
Oya, Yuko;
Watanabe, Naohiro;
Hasegawa, Takaaki;
Horio, Yoshitsugu;
Inaba, Yoshitaka;
Fujiwara, Yutaka

Publication type:

Article

First‐line osimertinib treatment in a patient with lung adenocarcinoma with coexisting epidermal growth factor receptorG719S and de novo T790M mutations.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 771, doi. 10.1111/1759-7714.14288

By:

Ito, Noriaki;
Masuda, Takeshi;
Ooka, Ikuko;
Hosoya, Takatsune;
Yamaguchi, Kakuhiro;
Sakamoto, Shinjiro;
Horimasu, Yasushi;
Nakashima, Taku;
Miyamoto, Shintaro;
Iwamoto, Hiroshi;
Fujitaka, Kazunori;
Hamada, Hironobu;
Hattori, Noboru

Publication type:

Article

CircRNA PRH1‐PRR4 stimulates RAB3D to regulate the malignant progression of NSCLC by sponging miR‐877‐5p.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 690, doi. 10.1111/1759-7714.14264

By:

Ma, Jun;
Li, Quanxing;
Li, Yuling

Publication type:

Article

Circ_0007580 knockdown strengthens the radiosensitivity of non‐small cell lung cancer via the miR‐598‐dependent regulation of THBS2.

Published in:

Thoracic Cancer, 2022, v. 13, n. 5, p. 678, doi. 10.1111/1759-7714.14221

By:

Yang, Zheng;
Wu, Hongfang;
Zhang, Kai;
Rao, Shilei;
Qi, Shuran;
Liu, Manxiang;
Chen, Ying;
Wang, Yang

Publication type:

Article

Issue Information.

Published in:: Thoracic Cancer, 2022, v. 13, n. 5, p. 657, doi. 10.1111/1759-7714.14019
Publication type:: Article